Suppr超能文献

动脉僵硬:冠心病的一种预后标志物。现有方法及临床应用

Arterial Stiffness: A Prognostic Marker in Coronary Heart Disease. Available Methods and Clinical Application.

作者信息

Bonarjee Vernon V S

机构信息

Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.

出版信息

Front Cardiovasc Med. 2018 Jun 11;5:64. doi: 10.3389/fcvm.2018.00064. eCollection 2018.

Abstract

Multiple biomarkers may predict short and long-term prognosis in patients with coronary heart disease, but their impact is limited when used in addition to established risk factors such blood pressure, cholesterol levels, diabetes mellitus, smoking as well as age and sex. Arteries are an integral part of the cardiovascular (CV) system. Arterial stiffness has been shown to be a predictor of cardiovascular events and mortality independent of traditional risk factors. It has also been shown that increased arterial stiffness may predict cardiovascular events in asymptomatic individuals without overt cardiovascular disease. Measuring arterial stiffness may, therefore, identify patients at risk at an early stage. Antihypertensive treatment has been shown to reduce arterial stiffness beyond its antihypertensive effect. Arterial stiffness could, therefore, be a surrogate marker of treatment that relates to prognosis. Arterial stiffness has mostly been used in research protocols, and its use as a prognostic indicator in clinical practice is still uncommon. Several methods exist that can determine parameters related to arterial stiffness, both local and in specific artery beds such as the aorta. In this brief review we present methods to evaluate arterial stiffness, their clinical utility, limitations and the advantages of a novel method, the Cardio-Ankle Vascular Index. Easier and more reproducible methods to evaluate arterial stiffness may increase the use of parameter as a risk factor for coronary heart disease in common clinical practice.

摘要

多种生物标志物可预测冠心病患者的短期和长期预后,但与血压、胆固醇水平、糖尿病、吸烟以及年龄和性别等既定风险因素一起使用时,其影响有限。动脉是心血管(CV)系统的一个组成部分。动脉僵硬度已被证明是心血管事件和死亡率的一个预测指标,独立于传统风险因素。研究还表明,动脉僵硬度增加可能预测无明显心血管疾病的无症状个体发生心血管事件。因此,测量动脉僵硬度可在早期识别有风险的患者。已证明抗高血压治疗可降低动脉僵硬度,其作用超出了降压效果。因此,动脉僵硬度可能是与预后相关的治疗替代指标。动脉僵硬度大多用于研究方案,在临床实践中用作预后指标仍不常见。有几种方法可确定与动脉僵硬度相关的参数,包括局部参数以及在特定动脉床(如主动脉)中的参数。在这篇简短综述中,我们介绍评估动脉僵硬度的方法、它们的临床效用、局限性以及一种新方法——心踝血管指数的优点。更简便且可重复性更强的评估动脉僵硬度的方法可能会增加该参数在普通临床实践中作为冠心病风险因素的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验